Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.62B |
| 2 |
Aon
AON
|
+$1.04B |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$901M |
| 4 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$823M |
| 5 |
Pinduoduo
PDD
|
+$770M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.19B |
| 2 |
Datadog
DDOG
|
+$747M |
| 3 |
TSMC
TSM
|
+$707M |
| 4 |
Baxter International
BAX
|
+$703M |
| 5 |
Estee Lauder
EL
|
+$592M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.28% |
| 2 | Healthcare | 10.85% |
| 3 | Financials | 9.94% |
| 4 | Consumer Discretionary | 8.39% |
| 5 | Industrials | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5501
Usio Inc
USIO
$64M
| $211K | ﹤0.01% |
121,434
-2,406
| -2% | -$4.43K |
|
5502
KORU Medical Systems
KRMD
$164M
| $211K | ﹤0.01% |
49,972
+22,176
| +80% | +$87.2K |
|
|
CURO
5503
DELISTED
CURO Group Holdings Corp.
CURO
| $210K | ﹤0.01% |
121,509
-109,112
| -47% | -$355K |
|
|
CBIO
5504
Crescent Biopharma
CBIO
$626M
| $210K | ﹤0.01% |
1,668
+1,505
| +923% | +$339K |
|
5505
Acumen Pharmaceuticals
ABOS
$176M
| $209K | ﹤0.01% |
51,508
+25,824
| +101% | +$135K |
|
5506
Playboy Inc
PLBY
$141M
| $208K | ﹤0.01% |
105,219
-70,073
| -40% | -$174K |
|
5507
Disc Medicine
IRON
$2.97B
| $208K | ﹤0.01% |
9,815
+8,994
| +1,095% | +$200K |
|
5508
Eagle Bancorp Montana
EBMT
$190M
| $208K | ﹤0.01% |
14,730
-3
| -0% | -$49 |
|
|
HEAL
5509
Global X Funds Global X HealthTech ETF
HEAL
$30.3M
| $208K | ﹤0.01% |
5,906
+367
| +7% | +$13.2K |
|
5510
JPMorgan Small & Mid Cap Enhanced Equity ETF
JMEE
$2.96B
| $208K | ﹤0.01% |
4,327
-402
| -9% | -$19.6K |
|
|
DOYU
5511
DouYu International Holdings
DOYU
$142M
| $207K | ﹤0.01% |
17,430
-68,872
| -80% | -$1.02M |
|
|
IMH
5512
DELISTED
Impac Mortgage Holdings Inc.
IMH
| $207K | ﹤0.01% |
592,062
+5,318
| +0.9% | +$1.86K |
|
5513
AAM S&P 500 High Dividend Value ETF
SPDV
$104M
| $207K | ﹤0.01% |
7,332
-582
| -7% | -$17K |
|
|
KZIA
5514
Kazia Therapeutics
KZIA
$159M
| $205K | ﹤0.01% |
3,989
-1,158
| -22% | -$55.6K |
|
5515
Absci
ABSI
$1.51B
| $205K | ﹤0.01% |
117,149
+8,871
| +8% | +$21.5K |
|
|
THRN
5516
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
| $205K | ﹤0.01% |
44,359
+25,533
| +136% | +$112K |
|
|
UXIN
5517
Uxin Ltd
UXIN
$282M
| $205K | ﹤0.01% |
9,144
+4,725
| +107% | +$139K |
|
5518
Global X MSCI Norway ETF
NORW
$88.2M
| $204K | ﹤0.01% |
8,401
-25,114
| -75% | -$630K |
|
|
URG
5519
Ur-Energy
URG
$556M
| $204K | ﹤0.01% |
192,084
-100,633
| -34% | -$114K |
|
5520
ProShares UltraShort Bloomberg Crude Oil
SCO
$728M
| $203K | ﹤0.01% |
2,016
-555
| -22% | -$57K |
|
|
TECX
5521
Tectonic Therapeutic
TECX
$606M
| $203K | ﹤0.01% |
16,904
-28,382
| -63% | -$395K |
|
5522
ProShares S&P 500 ex-Energy ETF
SPXE
$86.7M
| $203K | ﹤0.01% |
+4,650
| New | +$197K |
|
5523
CBL International Ltd
BANL
$7.92M
| $202K | ﹤0.01% |
+1,637
| New | +$153K |
|
5524
Dimensional International Small Cap ETF
DFIS
$6B
| $201K | ﹤0.01% |
+8,759
| New | +$200K |
|
|
LLAP
5525
DELISTED
Terran Orbital Corporation
LLAP
| $201K | ﹤0.01% |
109,067
+12,306
| +13% | +$23.7K |
|
Similar funds
Morgan Stanley's Q1 2023 Portfolio in Review
As of Q1 2023, Morgan Stanley held 8,043 positions worth $933B, up 5.9% from $880B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q1 2023 filing shows 163 new, 3,525 increased, 3,121 reduced and 300 closed positions. Its largest new stake was Calvert US Large-Cap Diversity, Equity and Inclusion Index ETF: 400,000 shares worth $20.8M. The largest sale was Apple, an estimated $1.19B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q1 2023 buy was Calvert US Large-Cap Diversity, Equity and Inclusion Index ETF: 400,000 shares worth $20.8M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $1.62B increase.
- Morgan Stanley's biggest Q1 2023 reduction was Apple, cutting an estimated $1.19B.
- Morgan Stanley fully exited SVB Financial Group in Q1 2023, selling an estimated $354M.
- Morgan Stanley's ten largest holdings make up 16% of its $933B portfolio in Q1 2023.
- Morgan Stanley opened 163 new positions and closed 300 in Q1 2023.
- Morgan Stanley's portfolio value rose 5.9% quarter-over-quarter to $933B.
Based on Morgan Stanley's 13F filing for Q1 2023, filed 15 May 2023.